122 companies

High Tide

Market Cap: CA$432.9m

Engages in the cannabis retail business in Canada.

HITI

CA$5.24

7D

3.8%

1Y

89.2%

Hanall Biopharma

Market Cap: ₩1.7t

A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.

A009420

₩32,850.00

7D

-0.8%

1Y

-15.2%

AFT Pharmaceuticals

Market Cap: NZ$292.6m

Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.

AFT

NZ$2.79

7D

7.7%

1Y

-12.8%

Kamada

Market Cap: ₪1.3b

Manufactures and sells plasma-derived protein therapeutics.

KMDA

₪23.02

7D

0.3%

1Y

15.8%

Valneva

Market Cap: €785.5m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

VLA

€4.95

7D

15.2%

1Y

90.5%

Aurora Cannabis

Market Cap: CA$488.9m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

ACB

CA$8.31

7D

19.7%

1Y

14.1%

Dynavax Technologies

Market Cap: US$1.1b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

DVAX

US$9.66

7D

-0.3%

1Y

-13.3%

Kiniksa Pharmaceuticals International

Market Cap: US$2.7b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

KNSA

US$38.77

7D

7.5%

1Y

55.1%

Takara Bio

Market Cap: JP¥112.2b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

4974

JP¥932.00

7D

-1.5%

1Y

-11.4%

Kidswell Bio

Market Cap: JP¥12.7b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

4584

JP¥267.00

7D

-2.6%

1Y

115.3%

Aarti Drugs

Market Cap: ₹44.3b

Through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.

524348

₹485.90

7D

-5.4%

1Y

-6.8%

Chugai Pharmaceutical

Market Cap: JP¥10.6t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519

JP¥6,448.00

7D

-3.5%

1Y

-8.8%

Jubilant Pharmova

Market Cap: ₹170.8b

Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.

530019

₹1,078.55

7D

-0.5%

1Y

-7.6%

Seegene

Market Cap: ₩1.1t

Manufactures and sells molecular diagnostics products worldwide.

A096530

₩24,750.00

7D

-5.7%

1Y

0%

JBM (Healthcare)

Market Cap: HK$2.4b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

2161

HK$2.99

7D

-0.3%

1Y

205.1%

Hyphens Pharma International

Market Cap: S$109.6m

Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.

1J5

S$0.35

7D

-5.3%

1Y

22.4%

Oxford Biomedica

Market Cap: UK£670.6m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

OXB

UK£5.58

7D

-5.3%

1Y

46.3%

Neurocrine Biosciences

Market Cap: US$14.1b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

New

NBIX

US$140.27

7D

-4.3%

1Y

21.7%

Green Thumb Industries

Market Cap: CA$2.3b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

GTII

CA$11.72

7D

11.5%

1Y

-17.1%

Medical Developments International

Market Cap: AU$80.6m

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.

MVP

AU$0.71

7D

8.3%

1Y

62.5%

Granules India

Market Cap: ₹125.3b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.

532482

₹516.20

7D

-1.4%

1Y

-10.9%

Essex Bio-Technology

Market Cap: HK$3.0b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

1061

HK$5.26

7D

0%

1Y

94.8%

IBN SINA Pharmaceutical Industry

Market Cap: ৳9.6b

Produces and sells pharmaceutical drugs in Bangladesh and internationally.

IBNSINA

৳307.30

7D

-2.1%

1Y

-15.8%

Emcure Pharmaceuticals

Market Cap: ₹242.6b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

EMCURE

₹1,279.90

7D

-3.4%

1Y

-14.4%

IOL Chemicals and Pharmaceuticals

Market Cap: ₹30.1b

Manufactures and sells pharmaceutical and chemical products in India and internationally.

New

524164

₹102.47

7D

-10.7%

1Y

7.9%

Eurofins Scientific

Market Cap: €10.8b

Provides various analytical testing and laboratory services worldwide.

ERF

€61.78

7D

-1.1%

1Y

8.8%

Vitrolife

Market Cap: SEK 17.6b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

VITR

SEK 129.70

7D

0.4%

1Y

-48.4%

hVIVO

Market Cap: UK£54.4m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

New

HVO

UK£0.078

7D

-6.0%

1Y

-72.1%

Aytu BioPharma

Market Cap: US$17.2m

A pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.

AYTU

US$1.71

7D

-31.3%

1Y

-27.2%

Vericel

Market Cap: US$1.5b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

New

VCEL

US$31.79

7D

-0.06%

1Y

-24.8%

Neuphoria Therapeutics

Market Cap: US$23.1m

A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.

NEUP

US$11.86

7D

20.3%

1Y

n/a

Repligen

Market Cap: US$7.1b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

RGEN

US$124.09

7D

-1.5%

1Y

-16.6%

Harmony Biosciences Holdings

Market Cap: US$1.6b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

HRMY

US$27.64

7D

-14.7%

1Y

-30.9%

Mayne Pharma Group

Market Cap: AU$418.4m

A specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

MYX

AU$5.15

7D

1.2%

1Y

8.0%

PeptiDream

Market Cap: JP¥203.2b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

4587

JP¥1,572.50

7D

-5.5%

1Y

-42.4%

Aroa Biosurgery

Market Cap: AU$224.3m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

ARX

AU$0.65

7D

-4.4%

1Y

18.2%

Page 3 of 4